Definition and validity of chronic kidney disease as a cardiovascular risk factor in the community-based population

慢性肾病作为社区人群心血管危险因素的定义和有效性

基本信息

  • 批准号:
    20590836
  • 负责人:
  • 金额:
    $ 2.91万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2008
  • 资助国家:
    日本
  • 起止时间:
    2008 至 2010
  • 项目状态:
    已结题

项目摘要

The definition of chronic kidney disease (CKD) which effectively discriminates high-risk subjects for cardiovascular events (CVE) from the Japanese general population has yet to be established. The aim of this study was to examine which definition of CKD might be useful for the prediction of CVE in our population. Baseline data including serum creatinine and proteinuria were determined in community- dwelling adults (n=14131, age=63). Estimated glomerular filtration rate (eGFR) was calculated using a modified MDRD equation, and CKD was defined by the three methods : (1) eGFR<60, (2) eGFR<60 or proteinuria positive, (3) eGFR<60 or proteinuria trace. CVE (stroke, heart failure, myocardial infarction/sudden death) were surveyed prospectively (mean follow-up = 2.7 years). As results, the most powerful definition of CKD for discriminating non-CKD in terms of CVE risk prediction was the definition of (3) (HR=1.36, 95%CI=1.07-1.74 ; p<0.05). In conclusion, the most useful definition of CKD for CVE risk-prediction in the Japanese general population appears to be eGFR<60 and/or urine protein trace.
尚未确定可有效区分心血管事件(CVE)高风险受试者与日本普通人群的慢性肾脏疾病(CKD)定义。本研究的目的是检查CKD的定义可能有助于预测我们人群中的CVE。基线数据包括血清肌酐和蛋白尿测定社区居住的成年人(n = 14131,年龄= 63)。采用改良MDRD公式计算肾小球滤过率(eGFR),以eGFR <60、eGFR <60或蛋白尿阳性、eGFR <60或微量蛋白尿3种方法定义CKD。对CVE(卒中、心力衰竭、心肌梗死/猝死)进行了前瞻性调查(平均随访= 2.7年)。结果表明,在CVE风险预测方面,用于区分非CKD的最有力的CKD定义是(3)的定义(HR = 1.36,95%CI = 1.07 - 1.74; p <0.05)。总之,在日本一般人群中,最有用的CKD定义是eGFR <60和/或尿蛋白微量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
危険因子「BNP」
风险因素“BNP”
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Abiko A;Makita S;Naganuma Y;Nagai M;Nakamura M;Yasukatsu Izumi;中村元行
  • 通讯作者:
    中村元行
Iwate KENCO Study Groups. Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population.
岩手县 KENCO 研究小组。
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakamura M;Tanaka F;Onoda T;Takahashi T;Sakuma M;Kawamura K;Tanno K;Ohsawa M;Itai K;Sakata K;Makita S
  • 通讯作者:
    Makita S
Peripheral-BP, Central-BP, and PWV: Which is the Most Useful Predictor for Cardiovascular Events and Death in the General Population
外周血压、中枢血压和 PWV:哪个是一般人群心血管事件和死亡最有用的预测因子
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    小野寺正幸;中村元行;他
  • 通讯作者:
Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis
  • DOI:
    10.1016/j.metabol.2009.09.009
  • 发表时间:
    2010-05-01
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    Tamada, Makiko;Makita, Shinji;Nakamura, Motoyuki
  • 通讯作者:
    Nakamura, Motoyuki
Is Plasma B-type Natriuretic Peptide Measurement Valid for Prediction of Cardiovascular Events and Death in Chronic Kidney Disease? A Community-based Longitudinal Study.
血浆 B 型利尿钠肽测量对于预测慢性肾病患者的心血管事件和死亡是否有效?
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    佐久間雅文;中村元行;他
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAMURA Motoyuki其他文献

NAKAMURA Motoyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAMURA Motoyuki', 18)}}的其他基金

Development of Cardiovascular Risk Scoring System for Japanses Population
日本人群心血管风险评分系统的开发
  • 批准号:
    23591059
  • 财政年份:
    2011
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Validation of New Identified Cardiovascular Biomarkers in the Japanese General Population
在日本普通人群中验证新发现的心血管生物标志物
  • 批准号:
    18590786
  • 财政年份:
    2006
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects and Mechanisms of Exercise Training on Patients with Chronic Heart Failure due to Valvular Heart Disease
运动训练对瓣膜性心脏病慢性心力衰竭患者的影响及机制
  • 批准号:
    11670706
  • 财政年份:
    1999
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Peripheral vascular remodeling in patients with chronic heart failure
慢性心力衰竭患者周围血管重塑
  • 批准号:
    09670742
  • 财政年份:
    1997
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Endothelial function and exercise capacity in patients with chronic heart failure
慢性心力衰竭患者的内皮功能和运动能力
  • 批准号:
    07670802
  • 财政年份:
    1995
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Respiratory virus vaccination as public health strategy to protect against occurrence of acute stroke and myocardial infarction
呼吸道病毒疫苗接种作为预防急性中风和心肌梗塞发生的公共卫生策略
  • 批准号:
    469018
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Operating Grants
REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)
中风心肌梗死 4 中地理和种族差异的原因 (REGARDS-MI-4)
  • 批准号:
    10703232
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction
Caspase-9作为连接心肌梗死细胞坏死和凋亡的节点
  • 批准号:
    10666668
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction
Caspase-9 作为连接心肌梗死细胞坏死和凋亡的节点
  • 批准号:
    10504387
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
VasaPlex-based biologics for treatment of reperfusion injury after myocardial infarction
基于 VasaPlex 的生物制剂用于治疗心肌梗死后的再灌注损伤
  • 批准号:
    10382838
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)
中风心肌梗死 4 中地理和种族差异的原因 (REGARDS-MI-4)
  • 批准号:
    10527641
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
Disruptions in ST-Elevation Myocardial Infarction Transfer Networks and Cardiovascular Health of Rural Americans
ST 段抬高心肌梗死转移网络和美国农村心血管健康的中断
  • 批准号:
    10400956
  • 财政年份:
    2021
  • 资助金额:
    $ 2.91万
  • 项目类别:
Disruptions in ST-Elevation Myocardial Infarction Transfer Networks and Cardiovascular Health of Rural Americans
ST 段抬高心肌梗死转移网络和美国农村心血管健康的中断
  • 批准号:
    10210820
  • 财政年份:
    2021
  • 资助金额:
    $ 2.91万
  • 项目类别:
Disruptions in ST-Elevation Myocardial Infarction Transfer Networks and Cardiovascular Health of Rural Americans
ST 段抬高心肌梗死转移网络和美国农村心血管健康的中断
  • 批准号:
    10621158
  • 财政年份:
    2021
  • 资助金额:
    $ 2.91万
  • 项目类别:
The role of pericytes in scar formation following stroke and myocardial infarction
周细胞在中风和心肌梗死后疤痕形成中的作用
  • 批准号:
    10358534
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了